Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α‐chain crosslinking

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|16|1|131-141

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.16, Iss.1, 2018-01, pp. : 131-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrin Stabilization (Factor XIII), Fibrin Structure and Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 430-437

Karger

Access to resources Recommend Favorite

Simulated Point Mutations in the Aα-Chain of Human Fibrinogen Support a Role of the αC Domain in the Stabilization of Fibrin Gel

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 6, 2009-01 ,pp. : 417-427

Karger

Access to resources Recommend Favorite

Three Hemoglobin Variants Caused by a Single α-Chain Gene Mutation in a Chinese Family

By  

Acta Haematologica, Vol. 123, Iss. 2, 2009-12 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Factor VIII Inhibitors in Patients with Hemophilia A

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Factor XIII (FXIII) and angiogenesis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 19-25

John Wiley & Sons Inc

Access to resources Recommend Favorite